ITGB2 and Sepsis: A Designed-Ankyrin-Repeat-Protein, named F7, specifically targeting activated Mac-1, demonstrates therapeutic anti-inflammatory effects in mouse models of sepsis, myocarditis, and ischemia/reperfusion injury (65).